Adverum Biotechnologies files 1-for-10 reverse stock split effective March 21, 2024

Adverum Biotechnologies, Inc.

Board approved 1-for-10 reverse split on March 8; Certificate of Amendment filed March 20, effective 12:01 a.m. ET March 21.
Every 10 shares of common stock convert to 1 share; par value per share unchanged.
Total authorized shares remain 300 million; no fractional shares issued (cash in lieu).
Restated Certificate of Incorporation filed (restates but does not further amend), effective 12:02 a.m. ET March 21.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Adverum Biotechnologies, Inc.: Amended certificate of incorporation to effectuate a 1-for-10 reverse stock split (effective 2024-03-21).

Change: charter amendment
Effective: 2024-03-21

Exact text from the filing

On March 20, 2024, the Company filed the Certificate of Amendment with the Secretary of State of the State of Delaware to effect the Reverse Stock Split effective as of 12:01 a.m. Eastern time on March 21, 2024

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001193125-24-072709

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.